therapeutic 2,050 words KG: ent-dise-bfd8f32d
Contents

Section 253: Advanced Optogenetics and Chemogenetics for Circuit Manipulation in CBS/PSP

💊 Therapeutic Info
Nameent-dise-bfd8f32d

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (12)

Purinergic Signaling Polarization Control
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
Oligodendrocyte White Matter Vulnerability
Score: 0.65
Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Score: 0.63
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.48
Synthetic Biology Rewiring via Orthogonal Receptors
Score: 0.65
Vocal Cord Neuroplasticity Stimulation
Score: 0.52
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Ephrin-B2/EphB4 Axis Manipulation
Score: 0.64

Related Analyses (8)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived

Related Experiments (13)

Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40

See Also (15)

A 6-month & 18-month Prospective, Randomized, Placebo-c
clinical · Pages share 4 hypotheses
A Phase 2b, Multicenter, Randomized, Double-Blind, Plac
clinical · Pages share 4 hypotheses
A Multicenter, Phase III, Randomized, Double Blind, Pla
clinical · Pages share 4 hypotheses
A Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 4 hypotheses
OSK Reprogramming and Yamanaka Factors in Neurodegenera
mechanism · Pages share 4 hypotheses

Knowledge Graph (3 edges)

therapeutics-section-199-computational-pharmacology-cbs-psp describes ent-dise-bfd8f32d
therapeutics-cytoskeletal-dynamics-tubulin-targeting-cbs-psp describes ent-dise-bfd8f32d
therapeutics-section-156-pet-therapy-animal-assisted-interventions-cbs-psp describes ent-dise-bfd8f32d

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.